Evidence map›Paper›PMID 38615365›Full record

ArticleCNS neuroscience & therapeutics2024

Quercetin alleviates chronic unpredictable mild stress-induced depression-like behavior by inhibiting NMDAR1 with α2δ-1 in rats.

Mingyan Wang, Xin Wei, Yugai Jia, Chaonan Wang, Xinliu Wang, Xin Zhang, Depei Li, Yuanyuan Wang, Yonggang Gao

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Phytochemicals with potential NMDAR-inhibitory activities: a review of neuroprotective mechanisms against excitotoxicity.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. [ModifiedNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mingyan WangCollege of Integrative Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
Xin WeiCollege of Integrative Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
Yugai JiaCollege of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China.
Chaonan WangCollege of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China.
Xinliu WangCollege of Integrative Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
Xin ZhangCollege of Integrative Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
Depei LiDepartment of Medicine, University of Missouri, Columbia, Missouri, USA.
Yuanyuan WangCollege of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China.
Yonggang GaoCollege of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China.ORCID 0000-0001-6865-4260
Hebei University of Chinese Medicine · CNUniversity of Missouri · US

Funding

Central Guiding Local Science and Technology Development Fund Projects 236Z7702GDoctoral research Fund project of Hebei University of Traditional Chinese Medicine BSZ2019011Excellent Young Teacher Fundamental Research of Hebei University of Chinese Medicine YQ2020009Ministry of Education's 'Chunhui Plan' Cooperative Research Project 202200159Natural Science Fund Project of Hebei Province H2020423004Research Foundation of Education Department of Hebei Province QN2022006Special fund for basic scientific research expenses of provincial colleges and universities of Hebei University of Traditional Chinese Medicine YXTD2023003Traditional Chinese Medicine of the Natural Science Foundation of Hebei Province H2022423381
6 · The paper itself

Abstract

backgroundDepression is a serious mental disorder and the most prevalent cause of disability and suicide worldwide. Chronic unpredictable mild stress (CUMS) can lead to a significant acceleration of depression development. Quercetin (Que) is a flavonoid compound with a wide range of pharmacological effects. Recent studies have shown that quercetin can improve CUMS-induced depression-like behavior, but the mechanism of its improvement is still unclear. α2δ-1 is a regulatory subunit of voltage-gated calcium channel, which can interact with N-methyl-D-aspartate receptor (NMDAR) to form a complex.

objectiveIn this study, we found that Que could inhibit the increase of α2δ-1 and NMDAR expression in rat hypothalamus induced by CUMS. In pain, chronic hypertension and other studies have shown that α2δ-1 interacts with the NMDAR to form a complex, which subsequently affects the expression level of NMDAR. Consequently, the present study aimed to investigate the antidepressant effect of Que in vivo and in vitro and to explore its mechanism of action in terms of the interaction between α2δ-1 and NMDAR.

methodsRats were randomly exposed to two stressors every day for 4 weeks to establish a CUMS rat model, then sucrose preference test (SPT), forced swimming test (FST), tail suspension test (TST), and open field test (OFT) were performed to detect the behavior of CUMS rats, so as to evaluate whether the CUMS rat model was successfully established and the improvement effect of Que on CUMS-induced depression-like behavior in rats. Experimental techniques such as serum enzyme-linked immunosorbent assay (ELISA), immunofluorescence, Western blot, and co-immunoprecipitation, as well as in vitro experiments, were used to investigate the mechanisms by which Que exerts its antidepressant effects.

resultsBehavioral and ELISA test results showed that Que could produce a reduction in the excitability of the hypothalamic-pituitary-adrenal (HPA) axis in CUMS rats and lead to significant improvements in their depressive behavior. Western blot, immunofluorescence, and co-immunoprecipitation experiments showed that Que produced a decrease in NMDAR1 and α2δ-1 expression levels and interfered with α2δ-1 and NMDAR1 binding. In addition, the neural regulation mechanism of Que on antidepressant effect in PC12 cells knocked out α2δ-1 gene was further verified. Cellular experiments demonstrated that Que led to a reversal of up-regulation of NMDAR1 and α2δ-1 expression levels in corticosterone-injured PC12 cells, while Que had no effects on NMDAR1 expression in PC12 cells with the α2δ-1 gene knockout.

conclusionsQue has a good antidepressant effect and can significantly improve the depression-like behavior caused by CUMS. It exerts antidepressant effects by inhibiting the expression level of α2δ-1, interfering with the interaction between α2δ-1 and NMDAR, and then reducing the excitability of the HPA axis.

Indexed as

QuercetinReceptors, N-Methyl-D-AspartateAnimalsAntidepressive AgentsDepressionHumansHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemRatsAntidepressive AgentsQuercetinReceptors, N-Methyl-D-AspartateCUMSdepressionHPA axisNMDAR1quercetinα2δ‐1

Identifiers

PMID38615365
PMCPMC11016343
OpenAlexW4394792870

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.